TEM
Tempus AI, Inc.NASDAQHealthcare$47.39+0.77%ClosedMarket Cap: $8.23B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
16.81
P/S
6.47
EV/EBITDA
-37.97
DCF Value
$-89.96
FCF Yield
-4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
69.6%
Operating Margin
-18.8%
Net Margin
-19.3%
ROE
-59.9%
ROA
-16.9%
ROIC
-10.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $367.2M | 89.7% | $-48.2M | $-54.2M | $-0.30 | — |
| FY 2025 | $1.27B | 69.6% | $-238.6M | $-245.0M | $-1.41 | — |
| Q3 2025 | $334.2M | 61.6% | $-59.9M | $-80.0M | $-0.46 | — |
| Q2 2025 | $314.6M | 62.0% | $-61.8M | $-42.8M | $-0.25 | — |
| Q1 2025 | $255.7M | 60.7% | $-68.7M | $-68.0M | $-0.40 | — |
| Q4 2024 | $200.7M | 60.8% | $-50.7M | $-13.0M | $-0.08 | — |
| FY 2024 | $693.4M | 55.0% | $-691.1M | $-705.8M | $-4.60 | — |
| Q3 2024 | $180.9M | 58.5% | $-53.6M | $-75.8M | $-0.46 | — |
| Q2 2024 | $166.0M | 45.5% | $-533.5M | $-552.2M | $-3.66 | — |
| Q1 2024 | $145.8M | 53.3% | $-53.3M | $-64.7M | $-0.55 | — |
| Q4 2023 | $147.7M | 55.2% | $-52.3M | $-50.5M | $-0.44 | — |
| FY 2023 | $531.8M | 53.8% | $-196.1M | $-214.1M | $-1.73 | — |